SARDH
SARDH (sarcosine dehydrogenase, also known as SDH or DMGDHL1) is a mitochondrial matrix flavoprotein enzyme that converts sarcosine into glycine. It catalyses the last step of the oxidative degradation of choline to glycine. Browse Assay Genie's current range of SARDH research reagents below, or read on for the biology behind the target.
SARDH is an oxidoreductase that acts in the final step of the oxidative degradation of choline to glycine. It converts sarcosine into glycine through oxidative demethylation. The enzyme is localised to the mitochondrial matrix, where this part of one-carbon and choline catabolism takes place. It belongs to the GcvT family, and HGNC places it in the flavoprotein and oxidoreductase gene groups.
SARDH is distinct from another mitochondrial matrix enzyme, dimethylglycine dehydrogenase. That enzyme catalyses a reaction that forms sarcosine, which SARDH then demethylates, so the two act in sequence in the same pathway. The human SARDH gene encodes a protein annotated in UniProt as sarcosine dehydrogenase, mitochondrial. Alternatively spliced transcript variants have been described for the gene. Mouse and rat orthologs are both named Sardh.
The gene was previously listed under the symbols SDH and DMGDHL1. Mutations in SARDH are associated with sarcosinemia, which makes the gene and protein of interest in studies of sarcosine handling and choline metabolism. Researchers working on this target may use a SARDH antibody, SARDH ELISA kit or recombinant SARDH protein to examine expression and function in mitochondrial metabolism.
SARDH catalyses the last step of oxidative choline degradation to glycine, making it a key enzyme for studying this pathway.
The enzyme performs oxidative demethylation of sarcosine, so it is central to work on how sarcosine is processed in the mitochondrial matrix.
Mutations in the SARDH gene are associated with sarcosinemia, providing a genetic route into this metabolic condition.
As a matrix flavoprotein of the GcvT family, SARDH is a model for studying mitochondrial oxidoreductases and their neighbouring enzymes.
SARDH converts sarcosine into glycine by oxidative demethylation. In doing so it catalyses the last step of the oxidative degradation of choline to glycine. The enzyme works in the mitochondrial matrix, downstream of dimethylglycine dehydrogenase, which catalyses a reaction that forms sarcosine.
SARDH stands for sarcosine dehydrogenase; UniProt lists it as sarcosine dehydrogenase, mitochondrial. Aliases and previous symbols include SDH and DMGDHL1. The enzyme carries EC number 1.5.8.3, and NCBI notes that alternatively spliced transcript variants have been described.
Mouse and rat both have an ortholog named Sardh, so the gene is present in common model organisms. In humans, mutations in SARDH are associated with sarcosinemia. Check the datasheet of any product for its validated reactivity.
Other enzymes of choline and sarcosine metabolism and mitochondrial oxidoreductases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UL12; product specifications from Assay Genie datasheets.